TickerFacts.

Nuo Therapeutics, Inc. (AURX): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Older than the company's other figures. The latest EBITDA is for the year ended 2021-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Depreciation & Amortization, which EBITDA is computed from, under the concepts TickerFacts maps.

-$90.7K
Year ended 2021-12-31
2010-12-31: -$4.96M2011-12-31: -$2.88M2012-12-31: -$11.72M2013-12-31: -$17.00M2014-12-31: -$22.78M2015-12-31: -$40.58M2017-12-31: -$14.42M2018-12-31: -$1.40M2019-12-31: -$879.3K2020-12-31: -$378.1K2021-12-31: -$90.7K-$90.7K
2010-12-31 EBITDA (USD) 2021-12-31
Period endedEBITDAChange YoYSource filing
2021-12-31-$90.7Kn/m2023-04-17, From 2021-01-01
2020-12-31-$378.1Kn/m2022-04-15, From 2020-01-01
2019-12-31-$879.3Kn/m2022-04-15, From 2019-01-01
2018-12-31-$1.40Mn/m2019-04-16, From 2018-01-01
2017-12-31-$14.42Mn/a2019-04-16, From 2017-01-01
No annual figure between 2015-12-31 and 2017-12-31.
2015-12-31-$40.58Mn/m2016-10-24, From 2015-01-01
2014-12-31-$22.78Mn/m2016-10-24, From 2014-01-01
2013-12-31-$17.00Mn/m2015-03-31, From 2013-01-01
2012-12-31-$11.72Mn/m2014-03-31, From 2012-01-01
2011-12-31-$2.88Mn/m2013-03-18, From 2011-01-01
2010-12-31-$4.96Mn/a2012-03-29, From 2010-01-01